Floatz logo

Modufolin

Colorectal Neoplasm

Isofol Medical ABPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

118 Active assets in the Colorectal Neoplasm cohort.

Asset / SponsorPhaseRating
Capecitabine
Rutgers, The State University of New Jersey
Phase 4BBB
Eloxatin
Peking University Cancer Hospital & Institute
Phase 4BBB
FLUOROURACILUM
Rutgers, The State University of New Jersey
Phase 4BBB
Ferric Carboxymaltose [Ferinject]
Nottingham University Hospitals NHS Trust
Phase 4BBB
Irinotecan
Shanghai Zhongshan Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Modufolin is also rated in:

colorectal cancerDormant
BB
Indicative ·
67 / 100
View asset →
colonic neoplasmDormant
CCC
Indicative ·
48 / 100
View asset →
rectal carcinomaDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →